PTAB Reverses Course, Institutes Review Of Herceptin Patent
The Patent Trial and Appeal Board, in a rare move, has reconsidered an earlier decision and agreed to institute America Invents Act review of a Genentech Inc. patent covering the mega-blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article